Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient
•Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.
Gespeichert in:
| Veröffentlicht in: | Blood advances 2020-06, Vol.4 (11), p.2387-2391 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2391 |
|---|---|
| container_issue | 11 |
| container_start_page | 2387 |
| container_title | Blood advances |
| container_volume | 4 |
| creator | Oza, Aabha Rettig, Michael P. Powell, Phil O'Brien, Kathryn Clifford, David B. Ritchey, Julie Gehrs, Leah Hollaway, Julia Major, Eugene Fehniger, Todd A. Miller, Christopher A. Soon-Shiong, Patrick Rock, Amy DiPersio, John F. |
| description | •Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML. |
| doi_str_mv | 10.1182/bloodadvances.2019000664 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7284083</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2473952920312659</els_id><sourcerecordid>2409194786</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-56e83cb03df44446d5d3f360f52422adb28b4b41f6865f75b4f4218a2643ba263</originalsourceid><addsrcrecordid>eNqFkctu1DAUhiNERau2r4C8LIsU35I4GyQYcSmaAgtgazn2ydTg2MF2RmKDeAfekCfBo2kHusILX-T_fL99_qpCBF8SIujTwYVglNkqryFdUkx6jHHb8gfVCeUdq_uGdQ8Pe9ofV-cpfSka0rWs6emj6phRLrho-En148pniA6Wr9bXpEFpmSGqTfA2ZXTxrhaYPUE5gsoT-IzCiD5cr5HyBr1dfUbWI4XmkPLvn7-Uc2EDHqxGNzCpHOZgIZdTyjAhDc4VjvJpdqqAZpVtAZ5VR6NyCc5v19Pq06uXH1dv6vX711er5-ta867PddOCYHrAzIy8jNY0ho2sxWNDOaXKDFQMfOBkbEXbjF0z8JFTIhRtORvKzE6rZ3vuvAwTGF2so3JyjnZS8bsMysr7N97eyE3Yyo4KjgUrgItbQAzfFkhZTjbtPqU8hCVJynFPet6JnZfYS3UMKUUYDzYEy12C8l6C8m-CpfTxv888FN7lVQQv9gIozdpaiDLp0kcNxkbQWZpg_-_yB9tZtGE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2409194786</pqid></control><display><type>article</type><title>Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Oza, Aabha ; Rettig, Michael P. ; Powell, Phil ; O'Brien, Kathryn ; Clifford, David B. ; Ritchey, Julie ; Gehrs, Leah ; Hollaway, Julia ; Major, Eugene ; Fehniger, Todd A. ; Miller, Christopher A. ; Soon-Shiong, Patrick ; Rock, Amy ; DiPersio, John F.</creator><creatorcontrib>Oza, Aabha ; Rettig, Michael P. ; Powell, Phil ; O'Brien, Kathryn ; Clifford, David B. ; Ritchey, Julie ; Gehrs, Leah ; Hollaway, Julia ; Major, Eugene ; Fehniger, Todd A. ; Miller, Christopher A. ; Soon-Shiong, Patrick ; Rock, Amy ; DiPersio, John F.</creatorcontrib><description>•Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.</description><identifier>ISSN: 2473-9529</identifier><identifier>EISSN: 2473-9537</identifier><identifier>DOI: 10.1182/bloodadvances.2019000664</identifier><identifier>PMID: 32484854</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Exceptional Case Report ; Hematopoietic Stem Cell Transplantation ; Humans ; Immunosuppression ; Interleukin-15 - antagonists & inhibitors ; JC Virus ; Leukoencephalopathy, Progressive Multifocal - etiology ; Leukoencephalopathy, Progressive Multifocal - therapy ; Male ; United States</subject><ispartof>Blood advances, 2020-06, Vol.4 (11), p.2387-2391</ispartof><rights>2020 American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-56e83cb03df44446d5d3f360f52422adb28b4b41f6865f75b4f4218a2643ba263</citedby><cites>FETCH-LOGICAL-c479t-56e83cb03df44446d5d3f360f52422adb28b4b41f6865f75b4f4218a2643ba263</cites><orcidid>0000-0001-5719-1555 ; 0000-0002-8705-2887 ; 0000-0002-0429-3133</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284083/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284083/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32484854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oza, Aabha</creatorcontrib><creatorcontrib>Rettig, Michael P.</creatorcontrib><creatorcontrib>Powell, Phil</creatorcontrib><creatorcontrib>O'Brien, Kathryn</creatorcontrib><creatorcontrib>Clifford, David B.</creatorcontrib><creatorcontrib>Ritchey, Julie</creatorcontrib><creatorcontrib>Gehrs, Leah</creatorcontrib><creatorcontrib>Hollaway, Julia</creatorcontrib><creatorcontrib>Major, Eugene</creatorcontrib><creatorcontrib>Fehniger, Todd A.</creatorcontrib><creatorcontrib>Miller, Christopher A.</creatorcontrib><creatorcontrib>Soon-Shiong, Patrick</creatorcontrib><creatorcontrib>Rock, Amy</creatorcontrib><creatorcontrib>DiPersio, John F.</creatorcontrib><title>Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient</title><title>Blood advances</title><addtitle>Blood Adv</addtitle><description>•Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.</description><subject>Adult</subject><subject>Exceptional Case Report</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Immunosuppression</subject><subject>Interleukin-15 - antagonists & inhibitors</subject><subject>JC Virus</subject><subject>Leukoencephalopathy, Progressive Multifocal - etiology</subject><subject>Leukoencephalopathy, Progressive Multifocal - therapy</subject><subject>Male</subject><subject>United States</subject><issn>2473-9529</issn><issn>2473-9537</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctu1DAUhiNERau2r4C8LIsU35I4GyQYcSmaAgtgazn2ydTg2MF2RmKDeAfekCfBo2kHusILX-T_fL99_qpCBF8SIujTwYVglNkqryFdUkx6jHHb8gfVCeUdq_uGdQ8Pe9ofV-cpfSka0rWs6emj6phRLrho-En148pniA6Wr9bXpEFpmSGqTfA2ZXTxrhaYPUE5gsoT-IzCiD5cr5HyBr1dfUbWI4XmkPLvn7-Uc2EDHqxGNzCpHOZgIZdTyjAhDc4VjvJpdqqAZpVtAZ5VR6NyCc5v19Pq06uXH1dv6vX711er5-ta867PddOCYHrAzIy8jNY0ho2sxWNDOaXKDFQMfOBkbEXbjF0z8JFTIhRtORvKzE6rZ3vuvAwTGF2so3JyjnZS8bsMysr7N97eyE3Yyo4KjgUrgItbQAzfFkhZTjbtPqU8hCVJynFPet6JnZfYS3UMKUUYDzYEy12C8l6C8m-CpfTxv888FN7lVQQv9gIozdpaiDLp0kcNxkbQWZpg_-_yB9tZtGE</recordid><startdate>20200609</startdate><enddate>20200609</enddate><creator>Oza, Aabha</creator><creator>Rettig, Michael P.</creator><creator>Powell, Phil</creator><creator>O'Brien, Kathryn</creator><creator>Clifford, David B.</creator><creator>Ritchey, Julie</creator><creator>Gehrs, Leah</creator><creator>Hollaway, Julia</creator><creator>Major, Eugene</creator><creator>Fehniger, Todd A.</creator><creator>Miller, Christopher A.</creator><creator>Soon-Shiong, Patrick</creator><creator>Rock, Amy</creator><creator>DiPersio, John F.</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5719-1555</orcidid><orcidid>https://orcid.org/0000-0002-8705-2887</orcidid><orcidid>https://orcid.org/0000-0002-0429-3133</orcidid></search><sort><creationdate>20200609</creationdate><title>Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient</title><author>Oza, Aabha ; Rettig, Michael P. ; Powell, Phil ; O'Brien, Kathryn ; Clifford, David B. ; Ritchey, Julie ; Gehrs, Leah ; Hollaway, Julia ; Major, Eugene ; Fehniger, Todd A. ; Miller, Christopher A. ; Soon-Shiong, Patrick ; Rock, Amy ; DiPersio, John F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-56e83cb03df44446d5d3f360f52422adb28b4b41f6865f75b4f4218a2643ba263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Exceptional Case Report</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Immunosuppression</topic><topic>Interleukin-15 - antagonists & inhibitors</topic><topic>JC Virus</topic><topic>Leukoencephalopathy, Progressive Multifocal - etiology</topic><topic>Leukoencephalopathy, Progressive Multifocal - therapy</topic><topic>Male</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oza, Aabha</creatorcontrib><creatorcontrib>Rettig, Michael P.</creatorcontrib><creatorcontrib>Powell, Phil</creatorcontrib><creatorcontrib>O'Brien, Kathryn</creatorcontrib><creatorcontrib>Clifford, David B.</creatorcontrib><creatorcontrib>Ritchey, Julie</creatorcontrib><creatorcontrib>Gehrs, Leah</creatorcontrib><creatorcontrib>Hollaway, Julia</creatorcontrib><creatorcontrib>Major, Eugene</creatorcontrib><creatorcontrib>Fehniger, Todd A.</creatorcontrib><creatorcontrib>Miller, Christopher A.</creatorcontrib><creatorcontrib>Soon-Shiong, Patrick</creatorcontrib><creatorcontrib>Rock, Amy</creatorcontrib><creatorcontrib>DiPersio, John F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oza, Aabha</au><au>Rettig, Michael P.</au><au>Powell, Phil</au><au>O'Brien, Kathryn</au><au>Clifford, David B.</au><au>Ritchey, Julie</au><au>Gehrs, Leah</au><au>Hollaway, Julia</au><au>Major, Eugene</au><au>Fehniger, Todd A.</au><au>Miller, Christopher A.</au><au>Soon-Shiong, Patrick</au><au>Rock, Amy</au><au>DiPersio, John F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient</atitle><jtitle>Blood advances</jtitle><addtitle>Blood Adv</addtitle><date>2020-06-09</date><risdate>2020</risdate><volume>4</volume><issue>11</issue><spage>2387</spage><epage>2391</epage><pages>2387-2391</pages><issn>2473-9529</issn><eissn>2473-9537</eissn><abstract>•Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32484854</pmid><doi>10.1182/bloodadvances.2019000664</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-5719-1555</orcidid><orcidid>https://orcid.org/0000-0002-8705-2887</orcidid><orcidid>https://orcid.org/0000-0002-0429-3133</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2473-9529 |
| ispartof | Blood advances, 2020-06, Vol.4 (11), p.2387-2391 |
| issn | 2473-9529 2473-9537 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7284083 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Adult Exceptional Case Report Hematopoietic Stem Cell Transplantation Humans Immunosuppression Interleukin-15 - antagonists & inhibitors JC Virus Leukoencephalopathy, Progressive Multifocal - etiology Leukoencephalopathy, Progressive Multifocal - therapy Male United States |
| title | Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A39%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-15%20superagonist%20(N-803)%20treatment%20of%20PML%20and%20JCV%20in%20a%20post%E2%80%93allogeneic%20hematopoietic%20stem%20cell%20transplant%20patient&rft.jtitle=Blood%20advances&rft.au=Oza,%20Aabha&rft.date=2020-06-09&rft.volume=4&rft.issue=11&rft.spage=2387&rft.epage=2391&rft.pages=2387-2391&rft.issn=2473-9529&rft.eissn=2473-9537&rft_id=info:doi/10.1182/bloodadvances.2019000664&rft_dat=%3Cproquest_pubme%3E2409194786%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2409194786&rft_id=info:pmid/32484854&rft_els_id=S2473952920312659&rfr_iscdi=true |